RadNet

RadNet, Inc. provides freestanding, fixed-site outpatient diagnostic imaging services in the United States. Its centers provide physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders and reduce unnecessary invasive procedures. The firm offers magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures. RadNet was founded by Howard G. Berger in 1980 and is headquartered in Los Angeles, CA.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

RadNet reports strong Q4 earnings, targets AI growth in 2023

RadNet's Q4 2022 performance demonstrated strong revenue and EBITDA growth, fueled by procedural demand and strategic investments in AI and expansion initiatives.
Despite challenges like labor market disruptions and a net loss, the company's focus on innovation, market positioning, and financial discipline bodes well for future profitability and growth.
Opportunities lie in AI revenue growth, de novo center profitability, and market expansion, positioning RadNet as a key player in the radiology industry with a clear path to sustained success.
With a commitment to quality services, shareholder value, and operational excellence, RadNet's strategic vision aligns with industry trends and growth opportunities, setting the stage for continued success and market leadership.

RadNet reports record Q1 revenue and EBITDA growth, eyes AI expansion

RadNet's Q1 2023 showcased strong financial performance and operational improvements. Despite challenges like net loss and labor inflation, the company is strategically positioned for growth through expansion and AI initiatives. Opportunities in advanced imaging services and cancer detection technologies present avenues for future success.

RadNet reports record Q2 earnings, eyes growth amid challenges

RadNet's Q2 2023 performance reflects strong revenue and EBITDA growth, driven by core Imaging Center segment.
While facing challenges like potential Medicare cuts and AI segment delays, the company is optimistic about growth opportunities.
Strategic initiatives in preventative medicine, AI, and outpatient services position RadNet for future success.
With a focus on innovation and financial strength, RadNet aims to capitalize on market shifts and technological advancements.

RadNet reports robust Q3 earnings, eyes growth through AI and partnerships

RadNet's Q3 performance reflects strong revenue growth and financial management, supported by AI division success and strategic initiatives for 2024.
Despite challenges such as staffing shortages and pricing discussions, the company's strengths in liquidity, debt management, and operational focus position it well for future growth.
Opportunities in acquisitions, AI investments, and partnerships offer avenues for expansion and innovation, driving RadNet's market leadership and service excellence.
Overall, RadNet's focus on growth, efficiency, and strategic partnerships underscores its commitment to sustainable success and market resilience in the healthcare industry.

RadNet reports record Q4 earnings, eyes AI growth opportunities

RadNet's Q4 2023 performance was strong, with record revenue and adjusted EBITDA driven by Imaging Center segment growth.
The company's focus on AI, acquisitions, and joint ventures presents growth opportunities but also challenges in reaching expansion targets.
Management's commitment to market leadership and financial strength positions RadNet well for future success and innovation.
RadNet's strategic investments and balance sheet strength support its growth initiatives and potential breakthroughs in AI solutions.

RadNet achieves record Q3 results, eyes AI growth opportunities

RadNet's Q3 2024 performance showcased exceptional financial results, underpinned by revenue growth, operational efficiency, and strategic guidance revisions for the full year.
The company's strengths lie in expansion initiatives, innovative collaborations, and a forward-looking approach towards technology commercialization and digital health advancement.
While facing challenges in regional adoption rates and program implementations, RadNet is well-positioned to capitalize on opportunities through strategic partnerships, AI profitability, and market expansion efforts.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

CAMBRIDGE, Mass. , Dec. 4, 2024 /PRNewswire/ -- Ketryx announced today that DeepHealth, Inc., a global leader in AI-powered health informatics and a wholly-owned subsidiary of RadNet, Inc. (Nasdaq: RDNT), has selected Ketryx to accelerate the delivery of AI-powered health informatics solutions.

Ketryx Announces DeepHealth Selected Its Software to Accelerate AI-Powered Health Informatics Innovation

Alcoa

GE Vernova LLC

Lumentum Holdings

Semtech

TG Therapeutics

Vericel

None of our picks is Nvidia or Amazon or Tesla. Investors may wish to widen the aperture to find the best stocks for outsize earnings growth.

Hunting For Magnificent Growth Next Year? Check Out These 7 Stocks.

RadNet's latest collaboration aims to create an AI-powered SmartTechnology to improve patient experience and operational efficiency in ultrasound.

RDNT Stock Up Post New Tie-Up to Boost Ultrasound Workflows With AI

RadNet's latest collaboration aims to create an AI control system for image interpretation to ensure AI scalability, performance monitoring and safety.

RDNT Stock Up Following the New Tie-Up to Leverage Radiology AI

LOS ANGELES, Dec. 02, 2024 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of fully-owned and operated outpatient imaging centers, today announced that Mark Stolper, Executive Vice President and Chief Financial Officer, will be presenting at the BofA Securities 2024 Leveraged Finance Conference in Boca Raton, FL on Tuesday, December 3, 2024 at 8:10 a.m. Eastern Time (5:10 a.m. Pacific Time).

RadNet, Inc. to Present at the BofA Securities 2024 Leveraged Finance Conference on December 3, 2024

LOS ANGELES and SOMERVILLE, Mass., Dec. 02, 2024 (GLOBE NEWSWIRE) --  DeepHealth, Inc., a global leader in AI-powered health informatics and a wholly-owned subsidiary of RadNet, Inc. (Nasdaq: RDNT), has launched new AI-powered solutions at RSNA 2024. These solutions enable breakthroughs in imaging-based diagnosis, population health screening programs, and efficient large-scale imaging operations. Moreover, DeepHealth launches SmartTechnology™ solutions that integrate advanced AI and informatics with imaging systems for more efficient, patient-centric workflows. This comprehensive portfolio, anchored on the cloud-native DeepHealth OS, is designed to improve operational efficiency, enhance clinical confidence, while elevating the experiences of patients and care teams. DeepHealth has established strategic collaborations with industry leaders in healthcare, medical imaging, AI, and cloud platforms to continuously innovate solutions, business models, and new care paradigms with the aim of empowering breakthroughs in care by unlocking the value of imaging.

RadNet's Wholly-Owned Subsidiary, DeepHealth, Launches New AI-powered Informatics and SmartTechnology™ Innovations at #RSNA2024

LOS ANGELES and SOMERVILLE, Mass., Dec. 01, 2024 (GLOBE NEWSWIRE) -- Siemens Healthineers and DeepHealth, Inc., a global leader in AI-powered health informatics and a wholly-owned subsidiary of RadNet, Inc. (Nasdaq: RDNT), today announced a strategic collaboration aimed at transforming ultrasound operations through the implementation of SmartTechnology™ by embedding AI-powered health informatics within workflows and imaging hardware. The collaboration will combine Siemens Healthineers' Acuson Sequoia ultrasound system, RadNet's expertise in high-volume outpatient care, and DeepHealth's SmartSonography™ solution powered by the cloud-native DeepHealth OS to tackle workflow and workforce challenges for enhanced operational efficiency and better patient experience.

Siemens Healthineers and RadNet's Wholly-Owned Subsidiary, DeepHealth, to Collaborate Around Elevating Ultrasound Workflows with AI-Powered SmartTechnology™

WILMINGTON, Del.--(BUSINESS WIRE)--Maverick Medical AI Announces Completion of The Implementation of Its Real-Time Autonomous Medical Coding Solution at RadNet.

Maverick Medical AI Announces Completion of The Implementation of Its Real-Time Autonomous Medical Coding Solution at RadNet

LOS ANGELES and SOMERVILLE, Mass., Dec. 01, 2024 (GLOBE NEWSWIRE) -- DeepHealth, Inc., a global leader in AI-powered health informatics and a wholly-owned subsidiary of RadNet, Inc. (NASDAQ: RDNT), today announced a strategic collaboration with CARPL.ai, a leading AI orchestration company that enables radiologists to access, assess, and integrate radiology AI solutions in their workflows. DeepHealth will use CARPL.ai's technology to develop an AI control system that can be commercialized and will be designed to monitor and optimize imaging AI performance for improved clinical outcomes, operational efficiency, and accelerated adoption of AI in radiology. AI monitoring is crucial to ensure reliable, accurate, and unbiased performance.

RadNet's Wholly-Owned Subsidiary, DeepHealth, to Use CARPL.ai's Platform to Develop a New AI Control System for Clinical AI Performance and Safety

SOMERVILLE, Mass., Nov. 29, 2024 (GLOBE NEWSWIRE) -- In a release issued under the same headline on Friday, November 29th by RadNet, Inc. (NASDAQ: RDNT), please note that in the third sentence of the first paragraph, the year that SmartMammo Dx was first cleared should be 2021, not 2012. The corrected release follows:

CORRECTION: RadNet's DeepHealth Subsidiary Expands FDA Clearance for SmartMammo™ Solution

SOMERVILLE, Mass., Nov. 29, 2024 (GLOBE NEWSWIRE) -- DeepHealth, Inc., a wholly-owned subsidiary of RadNet, Inc. (NASDAQ: RDNT) and a global leader in AI-powered health informatics, has received expanded FDA 510(k) clearance for its innovative mammography software. SmartMammo Dx, the AI algorithm within SmartMammo1, is now FDA-cleared to be compatible with GE HealthCare's Senographe Pristina™ mammography systems. SmartMammo Dx was first cleared in May 2012 in conjunction with HOLOGIC mammography systems, where its performance has also been tested and cleared in patients with unilateral breasts and with breast implants. This newly expanded clearance advances DeepHealth's mission to enhance and expand breast cancer screening programs by broadening system compatibility.

RadNet's DeepHealth Subsidiary Expands FDA Clearance for SmartMammo™ Solution

LOS ANGELES, Nov. 22, 2024 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT),  a national leader in providing high-quality, cost-effective, fixed-site outpatient diagnostic imaging services, today announced that it has completed pricing and allocations for Amendment No. 1 to Credit and Guaranty Agreement (the “First Amendment”) which will reduce the interest rates payable under its Third Amended and Restated First Lien Credit and Guaranty Agreement (the “Credit Agreement”).

RadNet Secures Commitments to Amend its Credit Facility, Resulting in 0.25% Reduction in Interest Rates

RadNet, Inc. (NASDAQ:RDNT ) Q3 2024 Earnings Conference Call November 11, 2024 10:30 AM ET Company Participants Mark Stolper - Executive Vice President & Chief Financial Officer Howard Berger - President & Chief Executive Officer Conference Call Participants Brian Tanquilut - Jefferies John Ransom - Raymond James Larry Solow - CJS Securities Jim Sidoti - Sidoti & Co. Operator Good day, and welcome to the RadNet, Inc., Third Quarter 2024 Financial Results Conference Call. All participants will be in a listen-only mode.

RadNet, Inc. (RDNT) Q3 2024 Earnings Call Transcript

GE HealthCare Technologies Inc

Radnet Inc   (NASDAQ:RDNT) stock is soaring, last seen up 24% to trade at $89.11 at last glance, after the company reported better-than-expected earnings and revenue for the third quarter.

RadNet Stock Pops on Earnings, GE HealthCare Partnership

CHICAGO--(BUSINESS WIRE)--Today, GE HealthCare (Nasdaq: GEHC) and DeepHealth, Inc., a global leader in AI-powered health informatics and a wholly-owned subsidiary of RadNet, Inc. (Nasdaq: RDNT), announced a strategic collaboration to further the innovation, commercialization, and adoption of AI in imaging. Together, the two companies aim to develop SmartTechnology™ solutions that harness the transformative power of AI to address key challenges across the imaging value chain, including helping i.

GE HealthCare and RadNet Forge Collaboration to Transform Imaging Systems and Accelerate the Adoption of Artificial Intelligence (AI) with SmartTechnology™

LOS ANGELES, Nov. 10, 2024 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective, fixed-site outpatient diagnostic imaging services through a network of 399 owned and operated outpatient imaging centers, today reported financial results for its third quarter of 2024.

RadNet Reports Third Quarter Financial Results with Record Quarterly Revenue and Adjusted EBITDA⁽¹⁾ and Revises Upwards 2024 Financial Guidance Ranges

RadNet (RDNT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

RadNet (RDNT) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

LOS ANGELES, Oct. 25, 2024 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of owned and operated outpatient imaging centers, announced today that it will host a conference call to discuss its third quarter 2024 financial results on Monday, November 11, 2024 at 7:30 a.m. Pacific Time (10:30 a.m. Eastern Time).

RadNet, Inc. Announces Date of its Third Quarter 2024 Financial Results Conference Call

RadNet (RDNT) possesses solid growth attributes, which could help it handily outperform the market.

3 Reasons Growth Investors Will Love RadNet (RDNT)

RadNet, the largest US diagnostic imaging operator, projects $1.8bn in 2024 revenue, driven by AI and Digital Health growth, and expanding imaging centers. Strong Q2 results with 13.9% revenue growth and 19.7% EBITDA increase, fueled by AI advancements and new imaging center openings. Future growth catalysts include market shifts to freestanding centers, increasing importance of joint ventures, and capital deployment for acquisitions and new facilities.

RadNet: Secular Tailwinds Underpinned By AI Monetization Prospects

LOS ANGELES, Sept. 17, 2024 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of fully-owned and operated outpatient imaging centers, today announced that Mark Stolper, Executive Vice President and Chief Financial Officer, will be presenting at the Sidoti & Company Small Cap 2024 Virtual Conference on Wednesday, September 18th at 4:00 p.m. Eastern Time.

RadNet, Inc. to Present at the Sidoti & Company Small Cap 2024 Virtual Conference on Wednesday, September 18th

LOS ANGELES, Sept. 12, 2024 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of fully-owned and operated outpatient imaging centers and digital health solutions, announced today the appointment of Kees Wesdorp as President and Chief Executive Officer of RadNet's Digital Health division and a member of the RadNet executive management team. Mr. Wesdorp will assume leadership for the company's Digital Health products and services, including the current portfolio of radiology informatics (eRAD Radiology Information/Image Management Systems and DeepHealth OS) and clinical Artificial Intelligence (AI) solutions in breast, prostate, lung and neuro marketed under the DeepHealth brand.

RadNet, Inc. Announces the Appointment of Kees Wesdorp as President and Chief Executive Officer of RadNet's Digital Health Division

CAMBRIDGE, Mass., Sept. 05, 2024 (GLOBE NEWSWIRE) -- DeepHealth, a wholly-owned subsidiary of RadNet, Inc. (NASDAQ: RDNT) and a global leader in AI-powered radiology and health informatics, today announces a data and AI development partnership with HOPPR (www.hoppr.ai). This collaboration will commercialize a pioneering Medical-Grade Generalized Foundational Model and foster the development of Fine-Tuned models for breast, prostate, and lung cancer detection, leveraging generative medical imaging-focused AI and robust, diverse data sets.

RadNet's DeepHealth and HOPPR Forge Partnership to Advance AI in Healthcare

LOS ANGELES, Sept. 03, 2024 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of fully-owned and operated outpatient imaging centers, today announced that Mark Stolper, Executive Vice President and Chief Financial Officer, will be presenting at the Morgan Stanley 22nd Annual Global Healthcare Conference on Thursday, September 5th, 2024 at 11:30 a.m. Eastern Time.

RadNet, Inc. to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference on Thursday, September 5th, 2024

RDNT stock is up 10% since my June publication following a strong set of quarterly numbers in its Q2 FY'24 earnings. Management continue executing on the growth route, recycling funds into new store openings. Same-store procedure volumes continue to ratchet higher, evidencing increased utilization of its legacy base.

News for RadNet Stock (RDNT)